Navigation Links
Singapore opens Fusionopolis, its second major R&D hub in 5 years
Date:10/17/2008

Singapore, 17 October 2008 Singapore's Prime Minister Lee Hsien Loong joined more than 400 international leaders in science, technology and business to celebrate the opening of Fusionopolis, its second major R&D hub. Its first major hub, Biopolis, opened five years ago.

The futuristic 30-hectare Fusionopolis, which will be developed over six phases, is the country's icon for research in the interactive media, physical sciences, engineering and technology.

"Fusionopolis offers a unique and powerful model for research and innovation," said Lim Chuan Poh, chairman of the multi-agency Fusionopolis Steering Committee and chairman of A*STAR (Agency for Science, Technology and Research), Singapore's leading public research agency whose science and engineering research institutes will be located at Fusionopolis.

Home to public sector research institutes and corporate labs, Fusionopolis is specially designed to break down the barriers in organisations and allow multidisciplinary teams from both national and corporate laboratories to flourish. This is critical to achieving breakthroughs in the face of highly-complex, large scale societal challenges confronting society today.

Added Lim, "An emblem of community and collaboration, Fusionopolis' physical infrastructure is designed to facilitate interactions and integration of groups of talent with diverse capabilities. This way, it builds a sense of community among the people here, and creates opportunities for them to contribute their capabilities as a vibrant and collaborative community, to impact lives and the world."

Charles Zukoski, Ph.D., who chairs A*STAR's Science and Engineering Research Council (SERC), pointed out, "With Fusionopolis, we are trying to create a new model of doing research that cuts across many different borders. This mixing of different interests and backgrounds will lead to unexpected solutions to problems about which society cares. It is a unique environment that I do not see anywhere else in the world."

Zukoski, a member of the prestigious U.S. based National Academy of Engineering, is the University of Illinois at Urbana-Champaign's William and Janet Lycan Professor in the Department of Chemical and Biomolecular Engineering.

Anchoring the development is A*STAR's science and engineering research institutes with world-class capabilities in data storage, materials science, infocomm, microelectronics, chemical synthesis, high-performance computing and manufacturing technologies.

Two research institutes have moved into phase 1 of the development, and another four will move into Fusionopolis by 2011, whereby they will form multidisciplinary teams tackling research that require a unique melding of skills.

The researchers will be joined by at least 13 corporate laboratories, which are located at phase 1 of the development.

These include Vestas, the world's leading wind turbine company; Ubisoft, one of Europe's largest game publisher; Linden Lab, the creator of Second Life; and Nitto Denko, a premier electronics and advanced materials company.

The University of Illinois at Urbana-Champaign will also open its first overseas research centre at Fusionopolis. Called the Advanced Digital Sciences Centre, it is an extension of two of UIUC's most successful multidisciplinary, information technology focused research units, namely the Coordinated Science Laboratory and the Information Trust Institute.

Altogether, there will be 800 scientists, engineers and game developers in phase 1 of Fusionopolis. This number will increase to 2,400 by 2012 when phase 2 of the development is ready.

The Fusionopolis research community can draw on the biomedical research expertise at Biopolis, which is located just half a mile away and is home to A*STAR's 13 biomedical research institutes, consortia and centres.

A*STAR has been actively encouraging collaborations between its 1,500 physical sciences researchers and engineers, and 1,000 biomedical researchers.

Breaking down barriers further is Fusionopolis' work-live-play-learn environment. The development comprises five levels of retail and F&B outlets, fitness facilities that include a rooftop swimming pool, a 50-unit serviced apartment, 13 sky gardens and an experimental theatre.

These facilities are aimed at creating a dynamic community at Fusionopolis and fostering chance encounters that could spark the next big discovery. Scientific facilities are also shared to encourage greater collaboration among the researchers. In addition, the lifestyle areas also double up as test bedding sites to accelerate the adoption of new technologies.

The opening of Fusionopolis comes as Singapore recorded the highest Gross Domestic Expenditure in R&D (GERD) of $4.2 billion (in Singapore dollars this amount equals $6.3 billion) in 2007, based on the preliminary results of the country's National R&D survey conducted by A*STAR.

The amount was an unprecedented increase of 26% from the 2006 GERD, and double the amount of $3 billion (Singapore dollars) recorded in 2000. GERD as a percentage of GDP rose to 2.61% in 2007, up from 2.31% in 2006 and 1.88% in 2000. Two thirds of this expenditure comes from the private sector.

Both Fusionopolis and Biopolis, which are part of the larger one-north development that is master planned and developed by JTC Corporation, are striking icons of the commitment by the government to transform Singapore into a knowledge-based, innovation-driven economy.

Government agencies with the mandate to grow the economy, including catalysing more R&D activities in the country, are located at Fusionopolis, reflecting the "whole-of-Singapore" approach to transform the economy.

The Media Development Authority is located at phase 1 of Fusionopolis. The Economic Development Board and SPRING Singapore will be located at phase 2A of Fusionopolis.


'/>"/>

Contact: Cathy Yarbrough
sciencematter@yahoo.com
858-243-1814
Agency for Science, Technology and Research (A*STAR), Singapore
Source:Eurekalert

Related biology news :

1. Singapores BIOPOLIS and FUSIONOPOLIS on stage in Boston this week
2. Ludwig Institute for Cancer Research to set up its first Asian branch in Singapore
3. Rare cancer-causing syndrome found, for the first time, in Singapore
4. Phase 2 of Singapores Biomedical Sciences Initiative gains momentum for clinical research
5. Singapore National Science and Technology Awards
6. IronKey Opens New European Office
7. Landmark study opens door to new cancer, aging treatments
8. Brown opens institute for molecular and nanoscale innovation
9. European light research opens door for optical storage and computing
10. New window opens on the secret life of microbes
11. Experimental Biology and Medicine announces expansion into Asia, opens new office
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/9/2016)... -- Paris Police Prefecture ... to ensure the safety of people and operations in several ... tournament Teleste, an international technology group specialised in ... that its video security solution will be utilised by ... safety across the country. The system roll-out is scheduled for ...
(Date:6/2/2016)... , June 2, 2016 The ... has awarded the 44 million US Dollar project, for ... Embossed Vehicle Plates including Personalization, Enrolment, and IT Infrastructure ... leader in the production and implementation of Identity Management Solutions. ... January, however Decatur was selected for ...
(Date:6/1/2016)... YORK , June 1, 2016 ... Technology in Election Administration and Criminal Identification to Boost ... to a recently released TechSci Research report, " Global ... By Region, Competition Forecast and Opportunities, 2011 - 2021", ... 24.8 billion by 2021, on account of growing security ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica delle Marche ... with peritoneal or pleural mesothelioma. Their findings are the subject of a new article ... Diagnostic biomarkers are signposts in the blood, lung fluid or tissue of mesothelioma patients ...
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)...  The Prostate Cancer Foundation (PCF) is pleased to announce 24 ... for prostate cancer. Members of the Class of 2016 were selected from a ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample tracking software ... State Crime Laboratory, has joined STACS DNA as a Field Application Specialist. , ... Tremblay, President and COO of STACS DNA. “In further expanding our capacity as a ...
Breaking Biology Technology: